Validation of Recombinase Polymerase Amplification with In-House Lateral Flow Assay for mcr-1 Gene Detection of Colistin Resistant Escherichia coli Isolates
dc.contributor.author | Ullah N. | |
dc.contributor.author | Suchanta N. | |
dc.contributor.author | Pimpitak U. | |
dc.contributor.author | Santanirand P. | |
dc.contributor.author | Am-In N. | |
dc.contributor.author | Chaichanawongsaroj N. | |
dc.contributor.correspondence | Ullah N. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2024-11-06T18:29:29Z | |
dc.date.available | 2024-11-06T18:29:29Z | |
dc.date.issued | 2024-10-01 | |
dc.description.abstract | Background/Objectives: The emergence of the mobilized colistin resistance 1 (mcr-1) gene, which causes colistin resistance, is a serious concern in animal husbandry, particularly in pigs. Although antibiotic regulations in many countries have prohibited the use of colistin in livestock, the persistence and dissemination of this plasmid-mediated gene require effective and rapid monitoring. Therefore, a rapid, sensitive, and specific method combining recombinase polymerase amplification (RPA) with an in-house lateral flow assay (LFA) for the mcr-1 gene detection was developed. Methods: The colistin agar test and broth microdilution were employed to screen 152 E. coli isolates from pig fecal samples of five antibiotic-used farms. The established RPA-in-house LFA was validated with PCR for mcr-1 gene detection. Results: The RPA-in-house LFA was completed within 35 min (20 min of amplification and 5–15 min on LFA detection) at 37 °C. The sensitivity, specificity, and accuracy were entirely 100% in concordance with PCR results. No cross-reactivity was detected with seven common pathogenic bacteria or other mcr gene variants. Conclusions: Therefore, the in-house RPA-LFA serves as a point-of-care testing tool that is rapid, simple, and portable, facilitating effective surveillance of colistin resistance in both veterinary and clinical settings, thereby enhancing health outcomes. | |
dc.identifier.citation | Antibiotics Vol.13 No.10 (2024) | |
dc.identifier.doi | 10.3390/antibiotics13100984 | |
dc.identifier.eissn | 20796382 | |
dc.identifier.scopus | 2-s2.0-85207640231 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/123456789/101907 | |
dc.rights.holder | SCOPUS | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Biochemistry, Genetics and Molecular Biology | |
dc.subject | Medicine | |
dc.subject | Immunology and Microbiology | |
dc.title | Validation of Recombinase Polymerase Amplification with In-House Lateral Flow Assay for mcr-1 Gene Detection of Colistin Resistant Escherichia coli Isolates | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85207640231&origin=inward | |
oaire.citation.issue | 10 | |
oaire.citation.title | Antibiotics | |
oaire.citation.volume | 13 | |
oairecerif.author.affiliation | Chulalongkorn University | |
oairecerif.author.affiliation | Faculty of Medicine Ramathibodi Hospital, Mahidol University |